ライフサイエンスコーパス: number of death

1 enterocyte apoptosis and greatly reduced the number of deaths.

2 ol and Prevention to identify the causes and number of deaths.

3 ne-adapted variant and reduce the cumulative number of deaths.

4 valuate the dose interval that minimizes the number of deaths.

5 nt of AKI, CKD, and compartment syndrome and number of deaths.

6 e screening uptake and prevent a significant number of deaths.

7 ebolaviruses in terms of mortality rate and number of deaths.

8 art attack and stroke that result in a large number of deaths.

9 ed treatments, leading to a disproportionate number of deaths.

10 is unlikely to be fulfilled, as only a small number of deaths (1% in the United Kingdom) occur in cir

11 There was no difference in the total number of deaths (101 vs 96 for tamoxifen vs raloxifene)

12 significant between-group differences in the number of deaths (19 [12%] in the liraglutide group vs 1

13 ort, there was more than double the expected number of deaths (2.05, 1.83-2.26).

14 stroke (37% and 47% increase, respectively), number of deaths (21% and 20% increase), and DALYs lost

15 The numbers of deaths--243 in the zoledronic acid group and

16 at 5 years and suffered only about half the number of deaths (25 vs. 46) during the period of observ

17 regnancy (35.7 weeks versus 37.0 weeks), the number of deaths (4 versus 1), final degree of heart blo

18 f diabetes, which accounted for an increased number of deaths (8% and 10%, respectively).

19 of 0.20 in relative risks almost doubled the number of deaths (97% overestimation).

20 andardized mortality ratio (the ratio of the number of deaths among handgun purchasers to the number

21 Increases in the incidence of cases and the number of deaths among infants during the 1990s primaril

22 stimate the prevalence, healthcare costs and number of deaths among people with chronic obstructive p

23 The increase in number of deaths among UN peacekeeping personnel since 1

24 The rising number of deaths among United Nations (UN) peacekeeping

25 The small number of deaths among women (n = 29) limited statistica

26 States, and Ukraine had the largest absolute numbers of deaths among the countries that provided data

27 hould be taken with caution, given the small number of deaths analyzed.

28 The actual number of deaths and each cause were obtained and the pr

29 the intention-to-treat analysis, the overall number of deaths and hospital admissions during three ma

30 using publicly available data for the daily number of deaths and hospitalisations, REACT-1 swab posi

31 The absolute number of deaths and hospitalizations averted because of

32 n/blinded follow-up of > or =6 weeks; 3) the number of deaths and modes of death were reported or cou

33 ear regression to examine the time trends in number of deaths and place of death, and Poisson regress

34 017 (GBD 2017), this study derived the total number of deaths and population size for each year from

35 ectional study: (1) an estimate of the total number of deaths and the proportion unreported by each s

36 The number of deaths and the sample size of each study arm w

37 sis showed a significant association between number of deaths and the strength (P<.001) and duration

38 The small number of deaths and the uncertainty in both diagnosis a

39 The numbers of deaths and all-cause, pregnancy-related morta

40 wide epidemic, with high attack rates, large numbers of deaths and hospitalizations, and wide disrupt

41 previous studies to estimate changes in the numbers of deaths and in life years and life expectancy

42 deaths by state, we estimated cause-specific numbers of deaths and mortality rates at the state, regi

43 th impact assessment methodology to estimate numbers of deaths and other adverse health outcomes that

44 In the past 30 years, the absolute numbers of deaths and people with disabilities owing to

45 ed 44.9% (95% CI: 44.2%, 45.4%) of the total number of deaths, and The Counted documented 93.1% (95%

46 lities, including infection scenarios, total number of deaths, and the distribution of deaths, which

47 age with quotes from district leaders on the numbers of deaths, and editorials on the failure of the

48 by two-thirds, is only possible if the high numbers of deaths are addressed by maternal, newborn, an

49 mortality rate in combination with the large number of deaths as compared to AF events in our study.

50 The number of deaths associated with COVID-19 is often used

51 The total number of deaths associated with dialysis-requiring AKI

52 he past decade in the United States, and the number of deaths associated with dialysis-requiring AKI

53 From 2003-2013, the number of deaths associated with HCV has now surpassed 6

54 In the CAPIRI vs IRI arms, the number of deaths at 6 months, 6-month OS, and median OS

55 According to our estimates, the total number of deaths at ages 5-14 years in low-income and mi

56 lity (YLLs) were computed by multiplying the number of deaths at each age by a reference life expecta

57 There was an increased number of deaths at the highest dose level.

58 By 2050, the number of deaths attributable to AMR in region is foreca

59 We calculated the change in the number of deaths attributable to climate-related changes

60 lso calculated the fraction of mortality and number of deaths attributable to nonoptimum temperatures

61 stimates may significantly underestimate the number of deaths attributable to smoking.

62 fatality rates were applied to calculate the number of deaths attributable to the vaccination clinic

63 Largest numbers of deaths attributable to this risk factor from

64 Primary outcomes were the number of deaths attributed to coronary heart disease, s

65 dose after 12 weeks of age would reduce the number of deaths averted by approximately 20%.

66 The total estimated number of deaths averted in the year 2003 was 90,043.

67 diet (SecDiet) probabilistic system, and the number of deaths averted was projected using the Prevent

68 The estimated number of deaths averted with azithromycin was 388 (95%

69 ention would result in the greatest absolute number of deaths averted.

70 ow-up, 509 of 1191 people died, the expected number of deaths being 496 (standardised mortality ratio

71 re in the scenarios resulted in an increased number of deaths being prevented, meaning that midwifery

72 11134 men were traced, and observed numbers of deaths between 1952 and 1997 were compared wi

73 g was associated with substantial changes in numbers of deaths between 1990 and 2017, but the attribu

74 However, the actual number of deaths by anaphylaxis, and their related trigg

75 The observed number of deaths by underlying cause were compared with

76 en younger than 5 years and birth rates, the numbers of deaths by cause were calculated for countries

77 Based on projected numbers of deaths by cause, years of life lived with dis

78 ed updated numbers of child deaths to derive numbers of deaths by causes.

79 Because a large number of deaths can be attributable to depression after

80 e bacteria are responsible for an increasing number of deaths caused by antibiotic-resistant infectio

81 ry occupation, they found an increase in the number of deaths caused by circulatory system diseases (

82 gorithm, which using as input the cumulative number of deaths caused by COVID-19, can estimate the ef

83 The already-alarming number of deaths caused by malaria is increasing, caused

84 The incidence of and number of deaths caused by pancreatic tumours have been

85 ords into 15 distinct strata and reduced the number of death certificate requests by 76%.

86 false, or questionable matches to reduce the number of death certificate requests to state offices.

87 , with consequent lag in capturing the total number of deaths compared to data reported on state dash

88 d consistently higher mortality and absolute number of deaths compared with low-risk patients using o

89 period from 1995 through 2000, yet the total number of deaths continued to increase.

90 d in many regions of the world, the absolute number of deaths continues to increase, with the majorit

91 d focus on perioperative mortality, a larger number of deaths could be avoided by focusing quality in

92 proximately 92% of the estimated decrease in number of deaths could be explained by the model; the re

93 duction in hospital acquired infections, the number of deaths could be reduced if healthcare provider

94 Cause of death rankings by total number of deaths, crude rates per 100 000 population, an

95 When calculated as the annual number of deaths divided by the total number of inpatien

96 ures, we estimate a 7.9-9.6% increase in the number of deaths due to breast cancer up to year 5 after

97 = 1.1) and a nonsignificant increase in the number of deaths due to cancers of the bronchus and lung

98 OVID-19 or living in countries with a higher number of deaths due to COVID-19.

99 The number of deaths due to CVD (SMR = 1.02, 95% CI = 0.9-1.

100 he authors found that there was an increased number of deaths due to digestive diseases (SMR = 1.7, 9

101 d population attributable risk for increased number of deaths due to other infectious diseases in chi

102 a District of Ghana were identified, and the number of deaths due to rotavirus disease was estimated

103 With the number of deaths due to stroke decreasing, more individu

104 The number of deaths during a median follow-up of 3.5 years

105 The number of deaths during follow-up was 10,624 in the 1976

106 We aimed to estimate the global number of deaths during the first 12 months of virus cir

107 vival Kaplan-Meier curves reflected a higher number of deaths during the first 6 months after randomi

108 ng different opioid-related outcomes-such as numbers of deaths, emergency department visits, and trea

109 al resistance is responsible for an alarming number of deaths, estimated at 5 million per year.

110 We then compared the number of deaths expected during the holiday period, giv

111 sion line to daily mortality to estimate the number of deaths expected during the holiday period, usi

112 lculation will not consistently estimate the number of deaths expected in the absence of exposure bec

113 Compared to number of deaths expected, we estimated a 33% (95% credi

114 Rs), absolute excess risks (AERs; [(observed number of deaths - expected number of deaths)/person-yea

115 COVID-19 interaction, and a greater absolute number of deaths following SARS-CoV-2 infection.

116 acteristics was used to predict the expected number of deaths for each TC.

117 an-Meier survival curves showed an increased number of deaths for patients at medium or high risk of

118 The number of deaths for which CLD was listed as a contribut

119 We aimed to estimate life tables and annual numbers of deaths for 187 countries from 1970 to 2010.

120 es of the risks, and derive estimates of the numbers of deaths for 1990 and 2010 by applying those ri

121 might experience a disproportionately large number of deaths (for example 48.7%), but there is wide

122 nstrated that acadesine decreased by 89% the number of deaths from 13.3% (13 deaths/98 MIs) in the pl

123 The expected number of deaths from all causes, all cancers, and ovari

124 The number of deaths from an index cancer did not differ sig

125 Estimates of the number of deaths from antimicrobial-resistant (AMR) infe

126 difference was seen among the groups in the number of deaths from any cause (169 deaths overall; P=0

127 by 54,000 to 99,000 and to reduce the annual number of deaths from any cause by 44,000 to 92,000.

128 The total number of deaths from any cause or disabling stroke at 1

129 breast cancer events was 115 (6.5%) and the number of deaths from breast cancer was 29 (1.6%).

130 tene group vs. 88 in the placebo group); the number of deaths from cancer (386 vs. 380), deaths from

131 proach for decreasing both the incidence and number of deaths from cancer.

132 The primary end point was the total number of deaths from cardiovascular causes and hospital

133 rge, resulted in a significantly lower total number of deaths from cardiovascular causes and hospital

134 ring the trial to the composite of the total number of deaths from cardiovascular causes, hospitaliza

135 ral Europe and Western Europe did the annual number of deaths from cardiovascular disease actually de

136 s, and more than half of the increase in the number of deaths from circulatory system diseases was a

137 difference between the observed and expected number of deaths from coronary heart disease in 2000 was

138 Oral rehydration therapy has reduced the number of deaths from dehydration caused by infection wi

139 Most of the increase in the number of deaths from digestive diseases was caused by c

140 des might have contributed to the increasing number of deaths from drug use disorders.

141 riety of statistical models to determine the number of deaths from each cause, through the Cause of D

142 After producing estimates for the number of deaths from each of the 282 fatal outcomes inc

143 and the smallest absolute decline was in the number of deaths from hyperglycemic crisis (-2.7; 95% CI

144 Number of deaths from liver disease, total costs, and cu

145 ning with low-dose CT prevented the greatest number of deaths from lung cancer among participants who

146 e incidence of lung cancer, it increased the number of deaths from lung cancer, in particular deaths

147 has contributed to a global increase in the number of deaths from malaria.

148 .52, p=0.01), mainly as a result of a higher number of deaths from non-small-cell lung cancer in the

149 associated with a reduction in the expected number of deaths from ovarian cancer in the cohort as a

150 biturates to benzodiazepines has reduced the number of deaths from pharmaceutical self-poisoning.

151 A plot of the annual rates of change in the number of deaths from pneumonia was used to generate hyp

152 creening rates in the control group, the low number of deaths from prostate cancer, and the relativel

153 Number of deaths from self-administration of lethal medi

154 However, given the number of deaths from stroke in the present cohort, a sm

155 risk localized prostate cancer decreases the number of deaths from this disease.

156 The numbers of deaths from adverse events (31 [5%] vs 35 [6%

157 The highest numbers of deaths from all causes and from heart disease

158 With increasing numbers of deaths from cancer, palliative care should be

159 y patterns of female workers were different: Numbers of deaths from homicide and unintentional trauma

160 Action and shooting games led to the largest numbers of deaths from violent acts, and we found a sign

161 iduals with CRC subtracted from the expected number of deaths had they not had CRC.

162 Cancer mortality rates, though not absolute numbers of deaths, have been decreasing over the last th

163 e costly transfer of patients and reduce the numbers of deaths; however, further study will be requir

164 The total number of deaths in 2001 attributed to CHD in patients o

165 Epidemiologists often compare the observed number of deaths in a cohort with the expected number of

166 Depending on the expected number of deaths in a future trial, the surrogate thresh

167 a infections cause a disproportionately high number of deaths in Africa, especially among poor urban

168 lated as the ratio of observed deaths to the number of deaths in an age-matched and sex-matched UK po

169 al model was developed to estimate the total number of deaths in children according to provinces, age

170 We did the following to derive the number of deaths in children aged 1-59 months: we used v

171 -2004 in the UK and caused an unusually high number of deaths in children.

172 deaths due to smoking increases, the annual number of deaths in China that are caused by tobacco wil

173 rebral hemorrhage (ICH) account for an equal number of deaths in China, despite a fourfold greater in

174 common seasonal pathogens, we estimated the number of deaths in elderly persons attributable to viru

175 The number of deaths in hepatitis C virus (HCV)-infected per

176 ed, and partly because of an increase in the number of deaths in infants sleeping with their parents

177 ding the donor pool, and its use reduces the number of deaths in patients awaiting orthotopic liver t

178 Failure to rescue was the number of deaths in patients with complications divided

179 n quintile 5, representing a 3.3-fold higher number of deaths in quintile 1 compared with quintile 5.

180 le way to consistently estimate the expected number of deaths in such settings, and we illustrate the

181 The total number of deaths in the 2 groups was identical (TIPS vs.

182 we averaged the models to estimate the true number of deaths in the analysis period.

183 We compared the observed number of deaths in the days preceding MI symptom onset

184 ases associated with the largest increase in number of deaths in the elderly.

185 There were significant increases in the number of deaths in the first week of the month for many

186 tates between 1973 and 1988, we compared the number of deaths in the first week of the month with the

187 A small number of deaths in the general population of patients w

188 will, in the foreseeable future, reduce the number of deaths in the industrialized world from cardio

189 aths in the first week of the month with the number of deaths in the last week of the preceding month

190 wever, these results were limited by the low number of deaths in the NET-PD LS-1.

191 ent data monitoring committee found a higher number of deaths in the rilotumumab group than in the pl

192 A substantial number of deaths in the United States could potentially

193 The number of deaths in this cohort was 3969 (13% mortality)

194 ustice supervision in England and Wales, the number of deaths in this population has more than double

195 e HZ vaccination program, the average annual number of deaths in which HZ was reported as the underly

196 There were similar numbers of deaths in all 3 arms (5, 5, and 4, respective

197 Updated total numbers of deaths in children aged 0-27 days and 1-59 mo

198 survey to the 2010 UN estimates of absolute numbers of deaths in India to estimate the number of sui

199 Final estimates were checked to ensure that numbers of deaths in specific age-sex groups did not exc

200 t factors and birth numbers to the change in numbers of deaths in under-5 age groups from 1990 to 201

201 es, hospitalizations were unchanged, and the number of deaths increased (RR, 1.98; 95% CI, 1.39-2.83)

202 In sub-Saharan Africa, the number of deaths increased by 20.8% from 1990 to 2019.

203 While the number of deaths increased steadily over time, heroin us

204 Annual numbers of deaths increased over time from 518 in 1999 t

205 Survival of FL cells is determined by a number of death-inhibiting proteins, among which bcl-xL

206 In the United States, the number of deaths is higher in the first week of the mont

207 sk into consideration, this reduction in the number of deaths is projected to produce a gain of 318 m

208 The small number of deaths limited the statistical power of the an

209 Final analysis after the preplanned number of deaths (n = 110) occurred after a median follo

210 0001), whereas the crude case fatality rate (number of deaths/number of cases) fell from 51.0% to 45.

211 from 1980 to 1989 had 28.9 times the excess number of deaths observed for survivors diagnosed either

212 ty for a 7-year observation period using the number of deaths observed in SLaM records compared with

213 ver 60 years, almost 30% of the total excess number of deaths observed were due to heart disease.

214 s, recurrence accounted for 7% of the excess number of deaths observed while second primary cancers a

215 period, given the null hypothesis, with the number of deaths observed.

216 mber of deaths in a cohort with the expected number of deaths, obtained by multiplying person-time ac

217 Equal numbers of deaths occurred during classes or other schoo

218 Approximately equal numbers of deaths occurred inside school buildings (n =

219 o childhood cancer because there are a large number of deaths occurring beyond 5-years (late mortalit

220 subnational variation in mortality rates and number of deaths of neonates, infants and children under

221 admissions was not due to an increase in the number of deaths of patients with acute coronary syndrom

222 ay 0 (11.2 per 1000 livebirths); the highest number of deaths on day 0 was seen in southern Asia (n=3

223 eed to intensify pharmacological treatment), number of deaths on day 30, and duration of treatment wi

224 e size of the candidate waiting list and the number of deaths on the waiting list are progressively i

225 the total patients on the waiting list, the number of deaths on the waiting list increased from 196

226 The number of deaths on treatment did not differ between the

227 ical trial failed to show a reduction in the number of deaths or complications with the addition of s

228 This design potentially reduces the number of deaths or other adverse outcomes incurred duri

229 re favorable outcomes and no increase in the number of deaths or vegetative states among the patients

230 dom error (which, in general, requires large numbers of deaths or of some other relevant outcome).

231 ects were seen with either antibiotic on the number of deaths, other medical conditions, behavioural

232 period, more than half (56.1%) of the total number of deaths otherwise projected.

233 We estimated the excess number of deaths over 1 year under different COVID-19 in

234 Although a higher number of deaths overall occurred in the 1 cm group comp

235 noncardiovascular deaths (36.5% of the total number of deaths) (P=0.0008).

236 The number of deaths per 1000 live births was 275 (95% confi

237 gorithm, using CoDCorrect to ensure that the number of deaths per cause did not exceed the total numb

238 For other drug overdose deaths, the mean number of deaths per day was 0.08 (SD = 0.28) on hot day

239 the proportion of violent game play and the number of deaths per minute of play.

240 For each winter, we estimated the number of deaths per month in excess of a base-line leve

241 On average across cities, the number of deaths (per 1,000 deaths) attributable to each

242 AERs; [(observed number of deaths - expected number of deaths)/person-years of observation] x10,000),

243 ated proportion of avoidable deaths, a total number of deaths possibly averted in the previous year w

244 d number of hospital deaths was close to the number of deaths predicted by the model, but when tested

245 e change in obesity prevalence and the total number of deaths prevented or postponed.

246 he range of estimated lower- and upper-bound number of deaths prevented per year with intensive SBP c

247 The potential numbers of deaths prevented or postponed as a result of

248 ses, is capable of cleaving and activating a number of death proteins in target cells.

249 ics can significantly reduce total costs and number of deaths, provided that the diagnostic gives res

250 The numbers of deaths (r=0.40, P=0.03) and years of life los

251 were summarized using risk ratios (RRs) for number of deaths/recurrences and hazard ratios (HRs), wi

252 However, the theoretical number of deaths reduced by eliminating physical inactiv

253 ainly accounted for by the relatively higher number of deaths related to human immunodeficiency virus

254 Importantly, the number of deaths related to infections was significantly

255 a larger and wealthier urban population, the number of deaths related to rural consumption is higher

256 126 recruits [51%]); however, a substantial number of deaths remained unexplained (44 of 126 recruit

257 This was more than twice the number of deaths reported in the next most severely impa

258 The total annual number of death reports generally decreased during the l

259 r the size of the epidemic, but the observed number of deaths represents only a minority of all infec

260 s disease 2019 (COVID-19); however, the true number of deaths resulting from COVID-19, both directly

261 However, a substantial number of deaths still occur every year from AIDS-relate

262 Despite accounting for a higher number of deaths than many other substantial public heal

263 We aimed to estimate the number of deaths that could be averted and the financial

264 y treatable conditions was estimated and the number of deaths that could have been avoided by providi

265 -hospital case fatality rate, defined as the number of deaths that occurred during index hospital adm

266 The number of deaths that occurred during treatment or less

267 we used the Lives Saved Tool to estimate the number of deaths that would be averted by 2035, if cover

268 enting a 28% (95% CI 26-33) reduction in the number of deaths that would be avoided because of change

269 amples collected in 1996 and ascertained the number of deaths through 2010.

270 million (10.8 million to 11.6 million), and number of deaths was 1.3 million (1.2 million to 1.4 mil

271 million (11.6 million to 12.2 million), and number of deaths was 1.4 million (1.3 million to 1.5 mil

272 The excess number of deaths was 13 for the first postoperative year

273 5% CI, 57,000 to 108,900), and the estimated number of deaths was 29,300 (95% CI, 16,500 to 42,100).

274 The expected number of deaths was 87 (standardized mortality ratio [S

275 The average number of deaths was about 5500 per day, or about 165,00

276 At week 60, the number of deaths was higher in the ozanezumab group (20

277 The mean number of deaths was highest in December at 1808 and Jan

278 The number of deaths was limited among subgroup analyses.

279 The number of deaths was not significantly different in the

280 The number of deaths was similar in the two groups.

281 31)I treatment, in absolute terms the excess number of deaths was small, and the underlying thyroid d

282 gical death rate was 1% (four patients); the number of deaths was too small for multivariate analysis

283 After extraction of causes and numbers of death, we analyzed NRM point estimates using

284 For 13 causes with low observed numbers of deaths, we developed negative binomial models

285 -methadone and forced-withdrawal groups, the number of deaths were one and zero, non-fatal overdoses

286 Beyond 30 days, a substantial number of deaths were related to the operation, especial

287 The numbers of deaths were as follows: 581 placebo-treated (

288 through 1998-1999 seasons, the greatest mean numbers of deaths were associated with influenza A(H3N2)

289 noncardiovascular deaths (47.5% of the total number of deaths), whereas in the rate-control arm, ther

290 We then compared the numbers of deaths with those given by the UN WPP itself

291 units (ICU) because of anaphylaxis, and the number of deaths within 10 days of presentation to the e

292 t and 45 percent, respectively), as were the numbers of deaths within 30 days after surgery.

293 Numbers of deaths within 7 days were increased (250/2807

294 ts with CF was observed in 2020, whereas the number of deaths without transplantation remained stable

295 nd devastating disease, such that the annual number of deaths (world-wide) from tobacco-related disea

296 us vaccine, we aimed to update the estimated number of deaths worldwide in children younger than 5 ye

297 s a severe medical condition causing a large number of deaths worldwide.

298 to the human brain and has been linked to a number of deaths worldwide.

299 fectious disease responsible for the highest number of deaths worldwide.

300 t in females and accounts for second highest number of deaths, worldwide.